{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:03:28Z","timestamp":1761563008892},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>BK polyomavirus-associated nephropathy (BKPyVAN) has become a major cause of kidney dysfunction and graft loss in kidney transplant recipients. On rare occasion, polyomavirus has also been known to affect native kidneys of immunocompromised individuals. Only a small number of opportunistic infections have been reported in the carrier phase of human T-lymphotropic virus type 1 (HTLV-1). This is the first reported case of BKPyVAN in native kidneys of an HTLV-1 carrier.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 61-year-old man was referred to our hospital from a primary care physician for work-up and treatment of pneumonia. He was diagnosed with <jats:italic>Pneumocystis<\/jats:italic> pneumonia and identified as a HTLV-1 carrier who had not yet developed adult T-cell leukemia (ATL). The pneumonia was successfully treated with sulfamethoxazole-trimethoprim. He had never been diagnosed with any kind of kidney dysfunction. Laboratory investigations showed a serum creatinine of 5.3\u00a0mg\/dL, and urinary sediment showed cells with nuclear enlargement and inclusion bodies suggesting viral infection. The urinary Papanicolaou stain showed inclusions in swollen, ground-glass nuclei, typical of \u201cdecoy cells\u201d. Renal biopsy showed degeneration of tubules with epithelial enlargement, vacuolar degeneration, nuclear inclusion bodies, and detachment from the tubular basement membrane. Tubular nuclei showed positive staining positive for simian virus 40 large-T antigen. Polymerase chain reaction tests for BK polyomavirus DNA of both urine and plasma were positive. These findings confirmed a diagnosis of BKPyVAN. Intravenous immunoglobulin therapy did not improve renal function, necessitating maintenance hemodialysis therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>BKPyVAN should be considered when acute kidney injury occurs with opportunistic infection. HTLV-1 carriers can develop opportunistic infections even before the onset of ATL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03373-1","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T11:02:10Z","timestamp":1698750130000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A case of acute kidney injury due to native kidney BK polyomavirus-associated nephropathy in a human T-lymphotropic virus type 1 carrier"],"prefix":"10.1186","volume":"24","author":[{"given":"Keita","family":"Takae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masumi","family":"Shojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nagae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Takata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritsuko","family":"Katafuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Masutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"3373_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/ndt\/gfz273","volume":"36","author":"SK Kolta","year":"2021","unstructured":"Kolta SK, Kadambi PV, Hendricks AR, Rojas R. BK polyomavirus-pathogen, paradigm and puzzle. Nephrol Dial Transplant. 2021;36:587\u201393.","journal-title":"Nephrol Dial Transplant"},{"key":"3373_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/aje\/kwv155","volume":"183","author":"A Gossai","year":"2016","unstructured":"Gossai A, Waterboer T, Nelson HH, Michel A, Willhauck-Fleckenstein M. Seroepidemiology of human polyomaviruses in a US population. Am J Epidemiol. 2016;183:61\u20139.","journal-title":"Am J Epidemiol"},{"key":"3373_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/ajt.16189","volume":"21","author":"V Nickeleit","year":"2021","unstructured":"Nickeleit V, Singh HK, Dadhania D, Cornea V, El-Husseini A. The Banff Working Group classification of definitive polyomavirus nephropathy: a multicenter validation study in the modern era. Am J Transplant. 2021;21:669\u201380.","journal-title":"Am J Transplant"},{"key":"3373_CR4","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981;78:6476\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3373_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.","journal-title":"Front Microbiol"},{"key":"3373_CR6","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1073\/pnas.81.8.2534","volume":"81","author":"M Yoshida","year":"1984","unstructured":"Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA. 1984;81:2534\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3373_CR7","doi-asserted-by":"publisher","unstructured":"Cook L, Rowan A, Bangham C. Adult T-cell leukemia\/lymphoma-pathobiology and implications for modern clinical management. Ann Lymphoma. 2021;5:29. Available from:\u00a0https:\/\/doi.org\/10.21037\/aol-21-6.","DOI":"10.21037\/aol-21-6"},{"key":"3373_CR8","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.2169\/internalmedicine.31.1132","volume":"31","author":"T Tashiro","year":"1992","unstructured":"Tashiro T, Yamasaki T, Nagai H, Kikuchi H, Nasu M. Immunological studies on opportunistic infection and the development of adult T-cell leukemia. Intern Med. 1992;31:1132\u20136.","journal-title":"Intern Med"},{"key":"3373_CR9","doi-asserted-by":"crossref","unstructured":"Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971;1:1253\u20137.","DOI":"10.1016\/S0140-6736(71)91776-4"},{"key":"3373_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0272-6386(95)90608-8","volume":"26","author":"R Purighalla","year":"1995","unstructured":"Purighalla R, Shapiro R, McCauley J, Randhawa P. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis. 1995;26:671\u20133.","journal-title":"Am J Kidney Dis"},{"key":"3373_CR11","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/genes13071290","volume":"14","author":"M Borriello","year":"2022","unstructured":"Borriello M, Ingrosso D, Perna AF, Lombardi A, Maggi P. BK virus infection and BK-virus-associated nephropathy in renal transplant recipients. Genes. 2022;14:1290.","journal-title":"Genes"},{"key":"3373_CR12","doi-asserted-by":"crossref","unstructured":"Shah A, Kumar V, Palmer MB, Trofe-Clark J, Laskin B. Native kidney BK virus nephropathy, a systematic review. Transpl Infect Dis. 2019;21:e13083.","DOI":"10.1111\/tid.13083"},{"key":"3373_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood.V58.3.645.645","volume":"58","author":"T Hattori","year":"1981","unstructured":"Hattori T, Uchiyama T, Toibana T, Takatsuki K, Uchino H. Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood. 1981;58:645\u20137.","journal-title":"Blood"},{"key":"3373_CR14","first-page":"317","volume":"43","author":"H Taguchi","year":"1989","unstructured":"Taguchi H, Miyoshi I. Immune suppression in HTLV-I carriers: a predictive sign of adult T-cell leukemia. Acta Med Okayama. 1989;43:317\u201321.","journal-title":"Acta Med Okayama"},{"key":"3373_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1006\/clin.1996.0131","volume":"80","author":"N Funai","year":"1996","unstructured":"Funai N, Shimamoto Y, Yoshida S, Nagai Y, Nakazato S. Differences in immune functions between human T-lymphotropic virus type 1 carriers and patients with adult T-cell leukemia\/lymphoma. Clin Immunol Immunopathol. 1996;80:325\u201332.","journal-title":"Clin Immunol Immunopathol"},{"key":"3373_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/iid3.432","volume":"9","author":"A Takatani","year":"2021","unstructured":"Takatani A, Nakamura H, Fukukawa K, Endo Y, Umeda M. Inhibitory effect of HTLV-1 infection on the production of B-cell activating factors in established follicular dendritic cell-like cells. Immun Inflamm Dis. 2021;9:777\u201391.","journal-title":"Immun Inflamm Dis"},{"key":"3373_CR17","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.2146\/ajhp160585","volume":"74","author":"AD Santeusanio","year":"2017","unstructured":"Santeusanio AD, Lukens BE, Eun J. Antiviral treatment of BK virus viremia after kidney transplantation. Am J Health Syst Pharm. 2017;74:2037\u201345.","journal-title":"Am J Health Syst Pharm"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03373-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03373-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03373-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T11:04:56Z","timestamp":1698750296000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03373-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3373"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03373-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"18 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of clinical details and clinical images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}